Submission Details
| 510(k) Number | K112414 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 22, 2011 |
| Decision Date | June 22, 2012 |
| Days to Decision | 305 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
K112414 is an FDA 510(k) clearance for the ELIA B2-GLYCOPROTEIN I IGA IMMUNOASSAY, a System,test,antibodies,b2 - Glycoprotein I (b2 - Gpi) (Class II — Special Controls, product code MSV), submitted by Phadia US, Inc. (Portae, US). The FDA issued a Cleared decision on June 22, 2012, 305 days after receiving the submission on August 22, 2011. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5660.
| 510(k) Number | K112414 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 22, 2011 |
| Decision Date | June 22, 2012 |
| Days to Decision | 305 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
| Product Code | MSV — System,test,antibodies,b2 - Glycoprotein I (b2 - Gpi) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5660 |